1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Osteoporosis Drugs Market in BRIC Nations 2015-2019

Osteoporosis Drugs Market in BRIC Nations 2015-2019

  • September 2015
  • -
  • Infiniti Research Limited
  • -
  • 68 pages

Summary

Table of Contents

Search Inside

About osteoporosis
Osteoporosis, or porous bone, is a disease characterised by low bone density and structural deterioration of bone tissue, leading to fragile bones. This increases the risk of fractures. Osteoporosis mainly affects women, but can also affect men. In women, bone loss occurs very rapidly in the first few years after menopause and continues through the postmenopausal stage. Osteoporosis progresses when bone resorption occurs too quickly or when replacement occurs too slowly. Risk factors for osteoporosis that cannot be controlled include gender, age, body size (low body weight), ethnicity, and family history. Risk factors that can be controlled include sex hormones, medication use, calcium and vitamin intake, alcohol intake, and smoking.

Technavio's analysts forecast the osteoporosis drugs market in BRIC nations to grow at a CAGR of 17.43% over the period 2014-2019.

Covered in this report
This report covers the present scenario and the growth prospects of the osteoporosis drugs market in BRIC nations for the period 2015–2019. To calculate the market size, the report considers revenue generated from the sales of various pharmaceutical products used in the treatment of osteoporosis. Pharmaceutical products are classified as branded and generic drugs.

Technavio's report, Osteoporosis Drugs Market in BRIC Nations 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Brazil, Russia, India, and China; it also covers the landscape of the osteoporosis drugs market in BRIC nations and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.

Key countries
- Brazil
- China
- India
- Russia

Key Vendors
- Amgen
- Eli Lilly
- Merck
- Novartis

Other prominent vendors
- Abiogen Pharma
- Deltanoid Pharmaceuticals
- F. Hoffmann La Roche
- GlaxoSmithKline
- IMMD
- Ligand Pharmaceuticals
- Pantarhei Bioscience
- Pfizer
- PhytoHealth
- Radius Health
- UPSHER-SMITH LABORATORIES
- Zosano Pharma

Market driver
- Increase in aging population
- For a full, detailed list, view our report

Market challenge
- Multiple patent expiries
- For a full, detailed list, view our report

Market trend
- Shift toward anabolic treatments
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Osteopenia & Osteoporosis Forecast in 13 Major Markets 2017-2027

Epiomic Epidemiology Series: Osteopenia & Osteoporosis Forecast in 13 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • February 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Osteopenia and Osteoporosis in13 Major Markets Osteopenia and osteoporosis (“porous bone”) are both terms which help to define ...

Juvenile idiopathic arthritis (JIA)- Market Insights, Epidemiology and Market Forecast-2023

Juvenile idiopathic arthritis (JIA)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Juvenile idiopathic arthritis (JIA) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of ...

Osteoporosis  - Market Insights, Epidemiology and Market Forecast-2023

Osteoporosis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Osteoporosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Osteoporosis for the seven major markets ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.